• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ZY

ZY

Zymergen Inc.

NASDAQBasic MaterialsChemicals - SpecialtyUS

USD2.43

+0.00 (+0.00%)

Company Profile

CEO

Joshua J. Hoffmann

IPO Date

2021-04-22

Sector

Basic Materials

Industry

Chemicals - Specialty

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.51

Prev. Close

$2.43

Day Low

$2.33

Day High

$2.58

52W Low

$1.10

52W High

$11.87

Volume

2.35M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

17.9%

Avg Negative

1.9%

Avg Neutral

80.2%

News Feed

Zymergen to Present at Goldman Sachs Annual Global Healthcare Conference

GlobeNewsWire·6/7/2021·↑ positive

Accelerator Life Science Partners' Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.

Business Wire·5/28/2021·↑ positive

Zymergen, Inc. (ZY) CEO Josh Hoffman on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/25/2021·
↓ negative

Zymergen Reports Preliminary First Quarter 2021 Financial Results

GlobeNewsWire·5/24/2021·↑ positive

Zymergen to Present at UBS Global Healthcare Virtual Conference

GlobeNewsWire·5/21/2021·↑ positive

What These 4 Top Analysts Love About Hot Biofacturing Firm Zymergen

24/7 Wall Street·5/17/2021·↑ positive

Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021

GlobeNewsWire·5/13/2021·↑ positive

This Is Why Zymergen's IPO Was a Huge Success

The Motley Fool·4/27/2021·↑ positive

Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·4/26/2021·↑ positive

Zymergen Rises 21% in Market Debut

Barrons·4/22/2021·↑ positive